Kangmei Pharma | 600518 - Net Income

Stock Price
1.87
Daily Change
-0.01 -0.53%
Monthly
-2.09%
Yearly
-14.61%
Q1 Forecast
1.84

Kangmei Pharma reported CNY-3.82M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Genomma Lab Internacional MXN 319.64M 114.43M Dec/2025
Hypermarcas BRL 457.64M 30.95M Sep/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Jiangsu Hengrui CNY 1.3B 1.27B Sep/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Sh Fosun Pharma CNY 821.33M 115.88M Sep/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -340.1M 211.9M Dec/2025
Wuxi Apptec CNY 3.51B 1.39B Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025